Should we use anticoagulation for patients with chronic heart failure?

被引：3

作者：

Freudenberger, Ronald S.

Halperin, Jonathan L.

机构：

[1] Univ Med & Dent New Jersey, Dept Med, Div Cardiovasc Dis & Hypertens, Heart Failure & Transplant Cardiol Program, New Brunswick, NJ 08901 USA

[2] Mt Sinai Sch Med, New York, NY USA

[3] Mt Sinai Med Ctr, Zena & Michael A Wiener Cardiovasc Inst, Clin Cardiol Serv, New York, NY USA

来源：

NATURE CLINICAL PRACTICE CARDIOVASCULAR MEDICINE | 2006年 / 3卷 / 11期

关键词：

D O I：

10.1038/ncpcardio0688

中图分类号：

R5 [内科学];

学科分类号：

1002 [临床医学]; 100201 [内科学];

摘要：

[No abstract available]

引用

页码：580 / 581

页数：2

共 10 条

[1]

Antiplatelet agents and survival: A cohort analysis from the studies of left ventricular dysfunction (SOLVD) trial [J].

Al-Khadra, AS ;

Salem, DN ;

Rand, WM ;

Udelson, JE ;

Smith, JJ ;

Konstam, MA .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 31 (02) :419-425

[2]

COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANTIPLATELET THERAPY .1. PREVENTION OF DEATH, MYOCARDIAL-INFARCTION, AND STROKE BY PROLONGED ANTIPLATELET THERAPY IN VARIOUS CATEGORIES OF PATIENTS [J].

ALTMAN, R ;

CARRERAS, L ;

DIAZ, R ;

FIGUEROA, E ;

PAOLASSO, E ;

PARODI, JC ;

CADE, JF ;

DONNAN, G ;

EADIE, MJ ;

GAVAGHAN, TP ;

OSULLIVAN, EF ;

PARKIN, D ;

RENNY, JTG ;

SILAGY, C ;

VINAZZER, H ;

ZEKERT, F ;

ADRIAENSEN, H ;

BERTRANDHARDY, JM ;

BRAN, M ;

DAVID, JL ;

DRICOT, J ;

LAVENNEPARDONGE, E ;

LIMET, R ;

LOWENTHAL, A ;

MORIAU, M ;

SCHAPIRA, S ;

SMETS, P ;

SYMOENS, J ;

VERHAEGHE, R ;

VERSTRAETE, M ;

ATALLAH, A ;

BARNETT, H ;

BATISTA, R ;

BLAKELY, J ;

CAIRNS, JA ;

COTE, R ;

CROUCH, J ;

EVANS, G ;

FINDLAY, JM ;

GENT, M ;

LANGLOIS, Y ;

LECLERC, J ;

NORRIS, J ;

PINEO, GF ;

POWERS, PJ ;

ROBERTS, R ;

SCHWARTZ, L ;

SICURELLA, J ;

TAYLOR, W ;

THEROUX, P .

BMJ-BRITISH MEDICAL JOURNAL, 1994, 308 (6921) :81-100

[3]

MANAGEMENT OF HEART-FAILURE .4. ANTICOAGULATION FOR PATIENTS WITH HEART-FAILURE DUE TO LEFT-VENTRICULAR SYSTOLIC DYSFUNCTION [J].

BAKER, DW ;

WRIGHT, RF .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 272 (20) :1614-1618

[4]

Ejection fraction and risk of thromboembolic events in patients with systolic dysfunction and sinus rhythm: Evidence for gender differences in the studies of left ventricular dysfunction trials [J].

Dries, DL ;

Rosenberg, YD ;

Waclawiw, MA ;

Domanski, MJ .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1997, 29 (05) :1074-1080

[5]

DUNKMAN WB, 1993, CIRCULATION, V87, P94

[6]

Freudenberger RS, 1996, MT SINAI J MED, V63, P342

[7]

FREUDENBERGER RS, IN PRESS J AM COLL C

[8]

MANIFESTATIONS OF CORONARY-DISEASE PREDISPOSING TO STROKE - THE FRAMINGHAM-STUDY [J].

KANNEL, WB ;

WOLF, PA ;

VERTER, J .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1983, 250 (21) :2942-2946

[9]

Aspirin and mortality in patients treated with angiotensin-converting enzyme inhibitors - A cohort study of 11,575 patients with coronary artery disease [J].

Leor, J ;

Reicher-Reiss, H ;

Goldbourt, U ;

Boyko, V ;

Gottlieb, S ;

Battler, A ;

Behar, S .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1999, 33 (07) :1920-1925

[10]

Ventricular dysfunction and the risk of stroke after myocardial infarction [J].

Loh, E ;

Sutton, MSJ ;

Wun, CCC ;

Rouleau, JL ;

Flaker, GC ;

Gottlieb, SS ;

Lamas, GA ;

Moye, LA ;

Goldhaber, SZ ;

Pfeffer, MA .

NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (04) :251-257

← 1 →